Profile data is unavailable for this security.
About the company
Toleranzia AB is a Sweden-based company engaged in the development of a platform technology for treatment of autoimmune diseases. The Company's main project is aimed against an autoimmune nerve-muscle disease and myasthenia gravis. The Company’s platform technology enables the development of therapies targeting the cause of the disease, which in the current situation is the usual treatment.
- Revenue in SEK (TTM)0.00
- Net income in SEK-6.30m
- Incorporated2011
- Employees7.00
- LocationToleranzia ABErik Dahlbergsgatan 11AGOETEBORG 411 26SwedenSWE
- Websitehttps://www.toleranzia.com/
More ▼